Novelna’s proteomics approach to early disease detection overcomes the limitations of traditional screening methods and demonstrates enhanced performance compared to other emerging approaches.

Proteomics

Proteomics is more than a measurement technique; it's a paradigm shift in early disease detection

Proteomics provides real-time insights into the body's dynamic responses to diseases like cancer. Genomics, transcriptomics, and metabolomics only have the ability to indicate predispositions, potential risks, or secondary changes. With proteomics we can detect molecular changes that occur long before the appearance of physical symptoms, making proteomics a more accurate indicator of disease states.